GoodRx CFO converts stock awards into 32,490 shares

The award vests in quarterly installments, subject to Justin Fengler's continued service through each applicable vesting date.

Rhea-AI Filing Summary

GoodRx Holdings, Inc. Chief Financial Officer and Chief Strategy & Operations Officer Justin Fengler reported converting 32,490 restricted stock units into 32,490 shares of Class A common stock on October 15, 2026. He also delivered or had withheld 14,247 shares at a reported $3.38 per share for payment of exercise price or tax liability. His reported post-transaction position was 292,410 restricted stock units. The award vests with respect to 1/12 in quarterly installments, subject to continued service through each applicable vesting date; no Rule 10b5-1 plan is reported.

Insider Trade Summary

32,490 shares exercised/converted

Exercise 3 txns

Insider Fengler Justin

Role See Remarks

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	32,490	$0.00	$0.00
Exercise	Class A Common Stock F1	32,490	--	--
Exercise Price or Tax Liability	Class A Common Stock	14,247	$3.38	$48K

Holdings After Transaction: Restricted Stock Unit — 292,410 contracts (Direct); Class A Common Stock — 70,752 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2. F2. This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on April 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Key Figures

Restricted stock units converted: 32,490 restricted stock units Class A common stock acquired: 32,490 shares Shares delivered or withheld: 14,247 shares +3 more

6 metrics

Restricted stock units converted 32,490 restricted stock units October 15, 2026 transaction

Class A common stock acquired 32,490 shares October 15, 2026 transaction

Shares delivered or withheld 14,247 shares For payment of exercise price or tax liability on October 15, 2026

Reported per-share price $3.38 per share For the 14,247 shares delivered or withheld

Restricted stock units following transaction 292,410 restricted stock units Reported post-transaction position

Vesting installment 1/12 of the award Quarterly installments, subject to continued service

Key Terms

restricted stock unit, contingent right, quarterly installments

3 terms

restricted stock unit financial

"Each restricted stock unit represents a contingent right"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"a contingent right to receive one share"

quarterly installments financial

"vests with respect to 1/12 of the award in quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GoodRx (GDRX) restricted stock units did Justin Fengler convert?

Justin Fengler reported converting 32,490 restricted stock units into 32,490 shares of Class A common stock on October 15, 2026. His reported post-transaction position was 292,410 restricted stock units.

What were the vesting terms for Justin Fengler's GoodRx (GDRX) award?

The award vests with respect to 1/12 of the award in quarterly installments, beginning on April 15, 2026 and on each quarterly anniversary thereafter. Vesting is subject to Justin Fengler's continued service through each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:22 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fengler Justin

(Last) (First) (Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA CALIFORNIA 90404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/15/2026		M		32,490	A	(1)	84,999	D
Class A Common Stock	10/15/2026		F		14,247	D	$3.38	70,752	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	10/15/2026		M			32,490	(2)	(2)	Class A Common Stock	32,490	$0	292,410	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

2. This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on April 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Remarks:

Chief Financial Officer and Chief Strategy & Operations Officer

	/s/ Gracye Cheng, Attorney-in-Fact for Justin Fengler	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)